Cargando…
The role of TOP2A in immunotherapy and vasculogenic mimicry in non-small cell lung cancer and its potential mechanism
Type IIA topoisomerase (TOP2A) is significantly associated with malignant tumor development, invasion, treatment and its prognosis, and has been shown to be a therapeutic target against cancer. In contrast, the role of TOP2A in the immunotherapy of non-small cell lung cancer as well as in Vasculogen...
Autores principales: | Wu, Jiatao, Zhang, Lei, Li, Wenjuan, Wang, Luyao, Jia, Qianhao, Shi, Fan, Li, Kairui, Liao, Lingli, Shi, Yuqi, Wu, Shiwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322841/ https://www.ncbi.nlm.nih.gov/pubmed/37407689 http://dx.doi.org/10.1038/s41598-023-38117-6 |
Ejemplares similares
-
Relationship between the expression of ARHGAP25 and RhoA in non-small cell lung cancer and vasculogenic mimicry
por: Shi, Fan, et al.
Publicado: (2022) -
Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
por: Wu, Shiwu, et al.
Publicado: (2012) -
Vasculogenic mimicry
por: Pandiar, Deepak, et al.
Publicado: (2023) -
Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma
por: Zhang, Shiwu, et al.
Publicado: (2008) -
Vasculogenic mimicry in small cell lung cancer
por: Williamson, Stuart C., et al.
Publicado: (2016)